ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2023

Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19.

Hong Foo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.